The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 3200 participants.
Also called NCT07905482
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,200 participants
- Sponsor
- Registry
-
NCT07905482
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07905482. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-05 (actual); primary completion 2029-03-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation During Manual Ventilation to Improve Neurological Outcomes at Discharge in Adult Patients Suffering an Out-of-hospital Cardiac Arrest
- Acronym
- REVIVE-PEEP
- Condition
- Cardiac Arrest, Out-Of-Hospital
- Intervention (Device)
- Fixed PEEP Valve
- Intervention (Device)
- Sham Valve
- Lead sponsor
- Jeroen van Eijk
- Collaborator
- Dutch Heart Foundation
- Collaborator
- Ambu A/S
Record details
- Record id
cardio:ct-nct07905482- Content hash
a5b94c9ef778efc182b48d76f3cec96a1d37d5bc0ea8ff67dec484be02906421